Brown S R, Johnson M A, Stevens L M. "一种的合成方法" [P]. US Patent, US 11057218 B2, 2023-03-13.
发明人赵玉洁,周伟,林芳. "Method for the Synthesis of 25775-96-6
2',4'-Dinitrophenyl-beta-galactopyranoside
beta-D-Galactopyranoside, 2,4-dinitrophenyl
2',4'-Dinitrophenyl beta-D-galactopyranoside
2,4-Dnp-gal" [P]. 中国发明专利, 专利号 CN 109819792 B, 授权公告日 2020-09-14.
Fischer A B, Lee S K, Klinger H. "A Process for Preparing High-Purity 25775-96-6
2',4'-Dinitrophenyl-beta-galactopyranoside
beta-D-Galactopyranoside, 2,4-dinitrophenyl
2',4'-Dinitrophenyl beta-D-galactopyranoside
2,4-Dnp-gal" [P]. US Patent, US 9092516 B2, 2021-05-26.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2010, 1194, (6), 8099-8129.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2024, 128, (8), 8529-8552.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 25775-96-6
2',4'-Dinitrophenyl-beta-galactopyranoside
beta-D-Galactopyranoside, 2,4-dinitrophenyl
2',4'-Dinitrophenyl beta-D-galactopyranoside
2,4-Dnp-gal Using HRMS and NMR". J. Sep. Sci., 2012, 801, 8509-8523.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2025, 1786, (12), 652-670.